FNDC5 and metabolic disease: Our metabolic results associated a cluster of FNDC5/irisin levels bring similar clinical evidence of this in-vitro study, and consolidate the studies that observed lower levels of FNDC5/irisin correlated with dysfunctions and metabolic diseases (6,8,29,30).